Short sellers switch to other Kosdaq-listed biotech stocks as Celltrion moves to Kospi

in #celltrion • 7 years ago

Biotech companies topped the short-selling chart of the secondary board on Feb. 8. About KRW 70.4 billion (USD 64.7 million) worth of Celltrion Healthcare shares, or about 14% of the overall transactions, were sold short on that day. Viromed, Medytox and SillaJen were also targeted by short sellers on Feb. 8 and the day after, the report said.

#viromed #medytox #silljen
7 years ago in #celltrion by
$0.00
    Reply 0

    Coin Marketplace

    STEEM 0.15
    TRX 0.23
    JST 0.032
    BTC 84505.80
    ETH 2355.78
    USDT 1.00
    SBD 0.67